Allworth Financial’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26K | Buy |
5,145
+1,221
| +31% | +$6.18K | ﹤0.01% | 2347 |
|
|
2025
Q1 | $22.6K | Buy |
3,924
+2,529
| +181% | +$14.5K | ﹤0.01% | 1999 |
|
|
2024
Q4 | $10.4K | Buy |
1,395
+1,329
| +2,014% | +$9.96K | ﹤0.01% | 2415 |
|
|
2024
Q3 | $435 | Buy |
66
+5
| +8% | +$33 | ﹤0.01% | 3446 |
|
|
2024
Q2 | $465 | Buy |
61
+26
| +74% | +$198 | ﹤0.01% | 3388 |
|
|
2024
Q1 | $349 | Hold |
35
| – | – | ﹤0.01% | 3372 |
|
|
2023
Q4 | $346 | Sell |
35
-15
| -30% | -$148 | ﹤0.01% | 3208 |
|
|
2023
Q3 | $383 | Buy |
50
+15
| +43% | +$115 | ﹤0.01% | 3104 |
|
|
2023
Q2 | $262 | Buy |
+35
| New | +$262 | ﹤0.01% | 3045 |
|